Page last updated: 2024-12-05

pseudoephedrine hydrochloride

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

pseudoephedrine hydrochloride : A hydrochloride that is the monohydrochloride salt of pseudoephedrine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID9581
CHEMBL ID1200724
CHEBI ID8604
SCHEMBL ID33285
MeSH IDM0423710

Synonyms (200)

Synonym
nsc-106567
nsc106567
CHEBI:8604 ,
(1s,2s)-2-(methylamino)-1-phenylpropan-1-ol hydrochloride
benzenemethanol, .alpha.-[(1s)-1-(methylamino)ethyl]-, hydrochloride, (.alpha.s)-
345-78-8
wln: qyr & y1 & m1 & gh-l
l-(+)-pseudoephedrine hydrochloride
tussaphed
benzenemethanol, hydrochloride, [s-(r*,r*)]-
1s,2s-(+)-pseudoephedrine hydrochloride
nsc-33634
d-[.alpha.-(1-methylamino)ethyl]benzyl alcohol hydrochloride
first sign
nsc33634
pseudophedrine hydrochloride
sudafed hydrochloride
benzenemethanol, hydrochloride, s-(r,r)-
(+)-pseudoephedrine hydrochloride
pseudoephedrine hydrochloride
d-pseudoephedrine hydrochloride
novafed
sudomyl
pseudoephedrine hydrochloride [usan]
pseudoephedrine hcl
benzenemethanol, alpha-(1-(methylamino)ethyl)-, hydrochloride, (s-(r*,r*))-
cpdd 0050
benzenemethanol, alpha-(1-(methylamino)ethyl)-, hydrochloride, (s-(theta,theta))-
sinufed
symptom 2
otrinol
nsc 106567
benzenemethanol, alpha-((1s)-1-(methylamino)ethyl)-, hydrochloride, (alphas)-
contac day & night allergy sinus day caplets
ornex and maximum strength ornex
sine-off maximum strength no drowsiness formula caplets
coadvil
d-(alpha-(1-methylamino)ethyl)benzyl alcohol hydrochloride
rhinalair
einecs 206-462-1
dimetapp decongestant
nsc 33634
sudafed 12 hour
benzenemethanol, alpha-(1-(methylamino)ethyl)-, (s-(r*,r*))-, hydrochloride
pseudoephedrine, hydrochloride, l-(+)-
dorcol
l(+)-pseudoephedrine hydrochloride
tylenol sinus medication, maximum strength
actifed sinus daytime
deconsal ii
pediacare decongestant drops
sudafed liquid, children's
(+)-pseudoephedrine hydrochloride, >=98%
D00485
sudafed (tn)
pseudoephedrine hydrochloride (usp)
SPECTRUM1500516
smr000718787
MLS001304069
efidac 24
CHEMBL1200724
galsud
HMS1920N04
(1s,2s)-2-(methylamino)-1-phenyl-1-propanol hydrochloride
P1654
isoephedrine hydrochloride
psi-ephedrine hydrochloride
nsc759616
pharmakon1600-01500516
nsc-759616
CCG-39241
ec 206-462-1
pseudoephedrine hydrochloride [usan:usp]
6v9v2ryj8n ,
nexafed
topcare 12 hour decongestant
benzenemethanol, alpha-((1s)-1-(methylamino)ethyl)-, hydrochloride (1:1), (alphas)-
sun mark sinus
sudafed 24 hour
suphedrine
unii-6v9v2ryj8n
pseudoephedrine hydrochloride component of myfed
children's advil cold component pseudoephedrine hydrochloride
bromfed-dm component pseudoephedrine hydrochloride
pseudoephedrine hydrochloride [who-dd]
isoclor component pseudoephedrine hydrochloride
advil allergy sinus component pseudoephedrine hydrochloride
aleve-d component pseudoephedrine hydrochloride
pseudoephedrine hydrochloride [usp-rs]
pseudoephedrine hydrochloride component of actahist
actahist component pseudoephedrine hydrochloride
sine-aid ib component pseudoephedrine hydrochloride
pseudoephedrine hydrochloride component of aleve-d
pseudoephedrine hydrochloride component of isoclor
pseudoephedrine hydrochloride component of children's advil cold
pseudoephedrine hydrochloride component of allegra-d
pseudoephedrine hydrochloride [mart.]
galpseud
pseudoephedrine hydrochloride [ep monograph]
pseudoephedrine hydrochloride component of codimal-l.a. 12
pseudoephedrine hydrochloride component of triacin-c
dimetane-dx component pseudoephedrine hydrochloride
pseudoephedrine hydrochloride [mi]
pseudoephedrine hydrochloride component of sine-aid ib
pseudoephedrine hydrochloride component of actifed
trilitron component pseudoephedrine hydrochloride
pseudoephedrine hydrochloride component of bromfed-dm
mucinex d component pseudoephedrine hydrochloride
codimal-l.a. 12 component pseudoephedrine hydrochloride
pseudoephedrine hydrochloride component of dimetane-dx
pseudoephedrine hydrochloride component of corphed
pseudoephedrine hydrochloride component of trilitron
histafed component pseudoephedrine hydrochloride
pseudoephedrine hydrochloride component of semprex-d
allerfed component pseudoephedrine hydrochloride
triacin-c component pseudoephedrine hydrochloride
semprex-d component pseudoephedrine hydrochloride
children's motrin cold component pseudoephedrine hydrochloride
allegra-d component pseudoephedrine hydrochloride
bromanate dm component pseudoephedrine hydrochloride
myfed component pseudoephedrine hydrochloride
pseudoephedrine hydrochloride component of allerfed
pseudoephedrine hydrochloride component of zyrtec-d
pseudoephedrine hydrochloride component of hycofenix
actifed component pseudoephedrine hydrochloride
zyrtec-d component pseudoephedrine hydrochloride
pseudoephedrine hydrochloride [usp monograph]
hycofenix component of pseudoephedrine hydrochloride
pseudoephedrine hydrochloride component of triphed
pseudoephedrine hydrochloride component of histafed
pseudoephedrine hydrochloride component of mucinex d
pseudoephedrine hydrochloride component of bromanate dm
pseudoephedrine hydrochloride [vandf]
pseudoephedrine hydrochloride component of children's motrin cold
pseudoephedrine hydrochloride [orange book]
corphed component pseudoephedrine hydrochloride
triphed component pseudoephedrine hydrochloride
pseudoephedrine hydrochloride component of advil allergy sinus
SCHEMBL33285
BALXUFOVQVENIU-KXNXZCPBSA-N
W-106727
pseudoephedrine hydrochloride, british pharmacopoeia (bp) reference standard
AKOS027383893
pseudoephedrine hydrochloride, united states pharmacopeia (usp) reference standard
(+)-pseudoephedrine hydrochloride, sigma reference standard
pseudoephedrine hydrochloride, european pharmacopoeia (ep) reference standard
pseudoephedrine hydrochloride, pharmaceutical secondary standard; certified reference material
(+)-pseudoephedrine hydrochloride 1.0 mg/ml in methanol (as free base)
Q27108108
pseudoephedrine hydrochloride; threo-ephedrine hydrochloride
DTXSID10889343
benzenemethanol, .alpha.-[(1s)-1-(methylamino)ethyl]-, hydrochloride (1:1), (.alpha.s)-
sinus decongestion
nasal decongestant d
sudogest 12 hour
sinus pressure and congestion reliefmaximum strength
walphed d
pseudoephedrine hydrochloride (mart.)
childrens sudafednasal decongestant
12 hour nasal decongestant
good sense suphedrine
walphed dmaximum strength non drowsy sinus
leader nasal decongestant
rugbynasal decongestant
pseudoephedrine hydrochloride (usp monograph)
equaline nasal decongestantnon drowsy maximum strength
sudafed sinus congestion 24 hour
sudafed sinus congestion 12 hour
topcare nasal decongestantmaximum strength non drowsy
harris teeter sinus
pseudoephedrine hydrochloride (usp-rs)
childrens sudafed
sudafed sinus congestion
sinus and congestionnon-drowsy
pseudoephedrine hydrochloride (ep monograph)
pseudoephedrine hydrochloride (usan:usp)
rugby nasal decongestantnasal decongestant
nasal decongestantmaximum strength, non-drowsy
picnic nasal decongestant
leader 12 hour nasal decongestant
zephrex-d
equate sinus 12 hour
zephrex d
pseudoephedrine.hcl
good neighbor pharmacy nasal decongestant
good sense nasal decongestant
pseudo-time
sudogest nasal decongestant
nasal decongestantmaximum strength non drowsy
childrens uniphednasal decongestant
equaline 12 hour decongestant
equaline nasal decongestant
careone nasal and sinus decongestant
pseudoephedrine hclunit dose
cvs health non-drowsy nasal decongestant
topcare nasal decongestant
good sense suphedrine12 hour
sinus and congestion
nasal decongestantd
(+)-pseudoephedrine.hcl

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" An understanding of structure-activity relationships (SARs) of chemicals can make a significant contribution to the identification of potential toxic effects early in the drug development process and aid in avoiding such problems."( Developing structure-activity relationships for the prediction of hepatotoxicity.
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ, 2010
)
0.36
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
hydrochlorideA salt formally resulting from the reaction of hydrochloric acid with an organic base.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
glp-1 receptor, partialHomo sapiens (human)Potency22.38720.01846.806014.1254AID624417
gemininHomo sapiens (human)Potency1.25890.004611.374133.4983AID624297
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (21)

Assay IDTitleYearJournalArticle
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588209Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset2010Chemical research in toxicology, Jul-19, Volume: 23, Issue:7
Developing structure-activity relationships for the prediction of hepatotoxicity.
AID625295Drug Induced Liver Injury Prediction System (DILIps) validation dataset; compound DILI positive/negative as observed in Pfizer data2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID588210Human drug-induced liver injury (DILI) modelling dataset from Ekins et al2010Drug metabolism and disposition: the biological fate of chemicals, Dec, Volume: 38, Issue:12
A predictive ligand-based Bayesian model for human drug-induced liver injury.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (8.33)29.6817
2010's10 (83.33)24.3611
2020's1 (8.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 83.99

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index83.99 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.39 (4.65)
Search Engine Demand Index160.07 (26.88)
Search Engine Supply Index2.23 (0.95)

This Compound (83.99)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (8.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (91.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]